Abstract:Aptamers are short single-stranded DNA, RNA, or synthetic Xeno nucleic acids (XNA) molecules that can interact with corresponding targets with high affinity. Owing to their unique features, including low cost of production, easy chemical modification, high thermal stability, reproducibility, as well as low levels of immunogenicity and toxicity, aptamers can be used as an alternative to antibodies in diagnostics and therapeutics. Systematic evolution of ligands by exponential enrichment (SELEX), an experimental approach for aptamer screening, allows the selection and identification of in vitro aptamers with high affinity and specificity. However, the SELEX process is time consuming and characterization of the representative aptamer candidates from SELEX is rather laborious. Artificial intelligence (AI) could help to rapidly identify the potential aptamer candidates from a vast number of sequences. This review discusses the advancements of AI pipelines/methods, including structure-based and machine/deep learning-based methods, for predicting the binding ability of aptamers to targets. Structure-based methods are the most used in computer-aided drug design. For this part, we review the secondary and tertiary structure prediction methods for aptamers, molecular docking, as well as molecular dynamic simulation methods for aptamer–target binding. We also performed analysis to compare the accuracy of different secondary and tertiary structure prediction methods for aptamers. On the other hand, advanced machine-/deep-learning models have witnessed successes in predicting the binding abilities between targets and ligands in drug discovery and thus potentially offer a robust and accurate approach to predict the binding between aptamers and targets. The research utilizing machine-/deep-learning techniques for prediction of aptamer–target binding is limited currently. Therefore, perspectives for models, algorithms, and implementation strategies of machine/deep learning-based methods are discussed. This review could facilitate the development and application of high-throughput and less laborious in silico methods in aptamer selection and characterization.

Computational tools for aptamer identification and optimization

Novel Insights into the Role of Aptamers in the Fight Against Cancer.

High-throughput and computational techniques for aptamer design

Artificial Intelligence in Aptamer–Target Binding Prediction

In Silico Design and Validation of High-Affinity RNA Aptamers Targeting Epithelial Cellular Adhesion Molecule Dimers

In silico selection of aptamers against SARS-CoV-2

Design and Prediction of Aptamers Assisted by In Silico Methods

Aptamer Bioinformatics

Current Status and Challenges of Aptamers Screening and Optimization.

Computational Frontiers in Aptamer-Based Nanomedicine for Precision Therapeutics: A Comprehensive Review

Oligonucleotide aptamers: Recent advances in their screening, molecular conformation and therapeutic applications

Progress in selection and biomedical applications of aptamers

Machine learning guided aptamer refinement and discovery

In silico design of novel aptamers utilizing a hybrid method of machine learning and genetic algorithm

Aptamers: Promising Reagents in Biomedicine Application

AptaDiff: de novo design and optimization of aptamers based on diffusion models

Recent Advances in Aptamer Discovery and Applications

Aptamers 101: aptamer discovery and in vitro applications in biosensors and separations

Analysis of aptamer discovery and technology

Aptamer Screening: Current Methods and Future Trend towards Non-SELEX Approach